B C Fauser

Summary

Affiliation: Division of Reproductive Medicine
Country: The Netherlands

Publications

  1. ncbi request reprint Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization
    B C Fauser
    Division of Reproductive Medicine, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands
    J Clin Endocrinol Metab 87:709-15. 2002
  2. ncbi request reprint [Publication of the results in all Dutch centers for in vitro fertilization: an important step towards an improvement in the effectiveness of the treatment]
    B C J M Fauser
    Erasmus Medisch Centrum, Centrum voor Voortplantingsgeneeskunde en afd Verloskunde en afd Verloskunde en Vrouwenziekten, Dr Molewaterplein 40, 3015 GD Rotterdam
    Ned Tijdschr Geneeskd 146:2335-8. 2002
  3. ncbi request reprint Alternative approaches in IVF
    Bart C J M Fauser
    Division of Reproductive Medicine, Erasmus University Medical Center Rotterdam, The Netherlands
    Hum Reprod Update 8:1-9. 2002
  4. ncbi request reprint Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antag
    D De Jong
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
    Fertil Steril 75:688-93. 2001
  5. ncbi request reprint Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility
    J S Laven
    Division of Reproductive Medicine, Department of Obstetrics and Gynaecology, Erasmus University Medical Centre Rotterdam, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Hum Reprod 16:1359-64. 2001
  6. ncbi request reprint Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development
    F P Hohmann
    Division of Reproductive Medicine, Department of Obstetrics and Gynaecology, Erasmus University Medical Center Rotterdam, The Netherlands
    Hum Reprod 16:846-54. 2001
  7. ncbi request reprint Follicle-stimulating hormone and advanced follicle development in the human
    N S Macklon
    Division of Reproductive Medicine, Department of Obstetrics and Gynaecology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
    Arch Med Res 32:595-600. 2001
  8. ncbi request reprint Aspects of ovarian follicle development throughout life
    N S Macklon
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Horm Res 52:161-70. 1999
  9. ncbi request reprint [Transfer of only a single embryo in in-vitro fertilisation]
    N S Macklon
    Erasmus Medisch Centrum, Centrum voor Voortplantingsgeneeskunde, Dr Molewaterplein 40, 3015 GD Rotterdam
    Ned Tijdschr Geneeskd 147:1301-4. 2003
  10. ncbi request reprint Regulation of follicle development and novel approaches to ovarian stimulation for IVF
    N Smacklon
    Department of Obstetrics and Gynaecology, Erasmus University Medical Center Rotterdam, The Netherlands
    Hum Reprod Update 6:307-12. 2000

Collaborators

Detail Information

Publications58

  1. ncbi request reprint Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization
    B C Fauser
    Division of Reproductive Medicine, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands
    J Clin Endocrinol Metab 87:709-15. 2002
    ..This more physiological approach for inducing oocyte maturation may represent a successful and safer alternative for in vitro fertilization patients undergoing ovarian hyperstimulation...
  2. ncbi request reprint [Publication of the results in all Dutch centers for in vitro fertilization: an important step towards an improvement in the effectiveness of the treatment]
    B C J M Fauser
    Erasmus Medisch Centrum, Centrum voor Voortplantingsgeneeskunde en afd Verloskunde en afd Verloskunde en Vrouwenziekten, Dr Molewaterplein 40, 3015 GD Rotterdam
    Ned Tijdschr Geneeskd 146:2335-8. 2002
    ....
  3. ncbi request reprint Alternative approaches in IVF
    Bart C J M Fauser
    Division of Reproductive Medicine, Erasmus University Medical Center Rotterdam, The Netherlands
    Hum Reprod Update 8:1-9. 2002
    ..Moreover, alternative compounds and ovarian stimulation protocols will be discussed, along with highlights in the development of the cryopreservation of excess oocytes or embryos. Finally, the health economics of IVF is addressed...
  4. ncbi request reprint Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antag
    D De Jong
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
    Fertil Steril 75:688-93. 2001
    ..The effect of GnRH antagonist on late follicular phase E(2) levels could not be exclusively attributed to suppression of LH...
  5. ncbi request reprint Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility
    J S Laven
    Division of Reproductive Medicine, Department of Obstetrics and Gynaecology, Erasmus University Medical Centre Rotterdam, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Hum Reprod 16:1359-64. 2001
    ....
  6. ncbi request reprint Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development
    F P Hohmann
    Division of Reproductive Medicine, Department of Obstetrics and Gynaecology, Erasmus University Medical Center Rotterdam, The Netherlands
    Hum Reprod 16:846-54. 2001
    ..Multifollicular growth per se has a distinct effect on luteal phase characteristics. These observations may be relevant for the design of mild ovarian stimulation protocols...
  7. ncbi request reprint Follicle-stimulating hormone and advanced follicle development in the human
    N S Macklon
    Division of Reproductive Medicine, Department of Obstetrics and Gynaecology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
    Arch Med Res 32:595-600. 2001
    ..Recognition of this concept has resulted in new approaches in ovulation induction treatment and ovarian hyperstimulation therapy for in vitro fertilization (IVF)...
  8. ncbi request reprint Aspects of ovarian follicle development throughout life
    N S Macklon
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Horm Res 52:161-70. 1999
    ..The menopause is preceded by a period of reduced fertility. The development of reliable and sensitive markers for ovarian ageing will be the challenge of the near future...
  9. ncbi request reprint [Transfer of only a single embryo in in-vitro fertilisation]
    N S Macklon
    Erasmus Medisch Centrum, Centrum voor Voortplantingsgeneeskunde, Dr Molewaterplein 40, 3015 GD Rotterdam
    Ned Tijdschr Geneeskd 147:1301-4. 2003
    ..The definition of success in IVF should be changed from number of children per IVF cycle to number of children born after singleton pregnancies per IVF treatment started...
  10. ncbi request reprint Regulation of follicle development and novel approaches to ovarian stimulation for IVF
    N Smacklon
    Department of Obstetrics and Gynaecology, Erasmus University Medical Center Rotterdam, The Netherlands
    Hum Reprod Update 6:307-12. 2000
    ..The benefits and risks of these minimal hyperstimulation protocols require further evaluation...
  11. ncbi request reprint Age-related differences in features associated with polycystic ovary syndrome in normogonadotrophic oligo-amenorrhoeic infertile women of reproductive years
    H Bili
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
    Eur J Endocrinol 145:749-55. 2001
    ..Although during reproductive years observed differences are relatively small, these age-related changes may affect the observed incidence of PCOS...
  12. ncbi request reprint [Androgens, well-being and libido in women]
    E J van Santbrink
    Erasmus Medisch Centrum, afd Verloskunde en Vrouwenziekten, sub afd Voortplantingsgeneeskunde, Dr Molewaterplein 40, 3015 GD Rotterdam
    Ned Tijdschr Geneeskd 147:1899-904. 2003
    ..Oestrogen deficiency should subsequently be ruled out or substituted. If the complaints still persist then androgen substitution can be considered...
  13. ncbi request reprint Multiple birth resulting from ovarian stimulation for subfertility treatment
    Bart C J M Fauser
    Department of Reproductive Medicine, University Medical Centre, Heidelberglaan 100, 3584 CX Utrecht, Netherlands
    Lancet 365:1807-16. 2005
    ..The background of ovarian hyperstimulation, trends supporting current practice, and strategies to reduce the chance of multiple pregnancy are highlighted...
  14. ncbi request reprint Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?
    Bart C J M Fauser
    Fertil Steril 83:1607-11. 2005
    ..The use of GnRH antagonist rather than agonist cotreatment during ovarian hyperstimulation for IVF is not widely accepted. Possible benefits, current shortcomings, and avenues for future development are discussed...
  15. ncbi request reprint Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility
    Annemarie G M G J Mulders
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus MC, Rotterdam, The Netherlands
    Hum Reprod 19:2036-42. 2004
    ....
  16. ncbi request reprint Individualized cost-effective conventional ovulation induction treatment in normogonadotrophic anovulatory infertility (WHO group 2)
    Marinus J C Eijkemans
    Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands
    Hum Reprod 20:2830-7. 2005
    ..We aimed to devise a patient-tailored, cost-effective treatment algorithm involving the above-mentioned treatment modalities, based on individual patient characteristics...
  17. ncbi request reprint Patient-tailored conventional ovulation induction algorithms in anovulatory infertility
    Evert J P van Santbrink
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus Medical Center, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Trends Endocrinol Metab 16:381-9. 2005
    ..This would make ovulation induction more cost-effective, safe and convenient, enabling doctors to advise patients on the most effective and patient-tailored treatment strategy...
  18. ncbi request reprint Does metformin modify ovarian responsiveness during exogenous FSH ovulation induction in normogonadotrophic anovulation? A placebo-controlled double-blind assessment
    Evert J P van Santbrink
    Division of Reproductive Medicine, Department of Obstetrics and Gynaecology, Erasmus Medical Centre, Rotterdam, The Netherlands
    Eur J Endocrinol 152:611-7. 2005
    ..To assess whether the addition of metformin to gonadotrophin ovulation induction in insulin-resistant, normogonadotrophic, anovulatory women alters ovarian responsiveness to exogenous FSH...
  19. ncbi request reprint Influence of oral contraceptive pills on phenotype expression in women with polycystic ovary syndrome
    Annemarie G M Mulders
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus Medical Centre, 3015 GD Rotterdam, The Netherlands
    Reprod Biomed Online 11:690-6. 2005
    ..Despite taking OCP, women still fulfilled the revised 2003 criteria for the syndrome, as PCO morphology was still present. Hence, OCP use does not appreciably affect the PCOS phenotype...
  20. ncbi request reprint Relationship between inhibin A and B, estradiol and follicle growth dynamics during ovarian stimulation in normo-ovulatory women
    Femke P Hohmann
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus Medical Center, Rotterdam, The Netherlands
    Eur J Endocrinol 152:395-401. 2005
    ....
  21. ncbi request reprint The science behind 25 years of ovarian stimulation for in vitro fertilization
    Nick S Macklon
    Department of Reproductive Medicine and Gynecology, University Medical Center Utrecht, P O Box 85500, 3508 GA Utrecht, The Netherlands
    Endocr Rev 27:170-207. 2006
    ..After a brief discussion of the relevant aspect of ovarian physiology, the development, application, and consequences of ovarian stimulation strategies are reviewed in detail...
  22. ncbi request reprint Ovulation induction in normogonadotropic anovulation (PCOS)
    Evert J P van Santbrink
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus Medical Center, Dr Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands
    Best Pract Res Clin Endocrinol Metab 20:261-70. 2006
    ..Regarding CC and FSH ovulation induction, this has been performed using multivariate prediction models. This approach may enable us to improve safety, cost-effectiveness, and patient convenience in future ovulation induction...
  23. doi request reprint Pregnancy complications in women with polycystic ovary syndrome
    Carolien M Boomsma
    Department of Reproductive Medicine and Gynecology, University Medical Center Utrecht, Utrecht, The Netherlands
    Semin Reprod Med 26:72-84. 2008
    ..Although metformin appears to be safe, there are too few data from prospective, randomized controlled trials to support treatment during pregnancy...
  24. ncbi request reprint A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study
    Olivier Valkenburg
    Department of Gynecology and Obstetrics, Division of Reproductive Medicine, Room HS 508, Erasmus Medical Center, P O Box 2040, 3000 CA Rotterdam, The Netherlands
    J Clin Endocrinol Metab 93:470-6. 2008
    ..Apolipoprotein (apo) A-I and apoB are potent markers for cardiovascular risk. Data on apo levels in women with PCOS are scarce and contradictory...
  25. ncbi request reprint Predictors of ongoing pregnancy after single-embryo transfer following mild ovarian stimulation for IVF
    Marieke F G Verberg
    Department of Reproductive Medicine and Gynecology, University Medical Center, Utrecht, The Netherlands
    Fertil Steril 89:1159-65. 2008
    ..To develop a prognostic model for the prediction of ongoing pregnancy after single-embryo transfer (SET) following mild stimulation for IVF in women less than 38 years of age...
  26. ncbi request reprint A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial
    Esther M E W Heijnen
    Department of Reproductive Medicine and Gynaecology, University Medical Centre, Utrecht, Netherlands
    Lancet 369:743-9. 2007
    ....
  27. doi request reprint The impact of ovarian stimulation with recombinant FSH in combination with GnRH antagonist on the endometrial transcriptome in the window of implantation
    Nick S Macklon
    Department of Reproductive Medicine and Gynecology, University Medical Center, Utrecht, Netherlands
    Reprod Sci 15:357-65. 2008
    ..These data suggest that dysregulation of the endometrial transcriptome in the stimulated cycle is not fully attributable to supraphysiological sex steroid levels at the folliculo-luteal transition...
  28. ncbi request reprint Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial
    Esther B Baart
    Department of Reproductive Medicine and Gynaecology, University Medical Center, Utrecht, The Netherlands
    Hum Reprod 22:980-8. 2007
    ....
  29. ncbi request reprint Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome
    Madelon van Wely
    Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Fertil Steril 86:1710-5. 2006
    ..To validate a published model for the prediction of the individual FSH response dose for gonadotropin induction of ovulation in polycystic ovary syndrome (PCOS)...
  30. ncbi request reprint The early luteal phase administration of estrogen and progesterone does not induce premature luteolysis in normo-ovulatory women
    Nicole G M Beckers
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus MC University Medical Center, Rotterdam, The Netherlands
    Eur J Endocrinol 155:355-63. 2006
    ..In the present study, high doses of steroids are administered after the LH surge in normo-ovulatory volunteers in order to investigate whether this intervention gives rise to endocrine changes and a shortening of the luteal phase...
  31. ncbi request reprint What role of estrogens in ovarian stimulation
    Joop S E Laven
    Division Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus Medical Center, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Maturitas 54:356-62. 2006
    ..The major focuses of these compounds are bone density, the cardiovascular system and breast cancer. No studies have been reported in the area of ovarian stimulation...
  32. ncbi request reprint Management of infertility in a patient presenting with ovarian dysfunction and McCune-Albright syndrome
    Joop S E Laven
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands
    J Clin Endocrinol Metab 89:1076-8. 2004
    ..Because a healthy baby was born, evidence is provided suggesting that MAS is not passed on to the children from the parents...
  33. ncbi request reprint A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH a
    Femke P Hohmann
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands
    J Clin Endocrinol Metab 88:166-73. 2003
    ..The relatively small number of oocytes obtained after mild ovarian stimulation may represent the best of the cohort in a given cycle...
  34. ncbi request reprint FSH response-dose can be predicted in ovulation induction for normogonadotropic anovulatory infertility
    Evert J P van Santbrink
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus Medical Center, GD, The Netherlands
    Eur J Endocrinol 147:223-6. 2002
    ..To evaluate the ability of a prediction model to identify the individual starting dose of FSH for ovulation induction using a step-down regimen...
  35. ncbi request reprint New approach to polycystic ovary syndrome and other forms of anovulatory infertility
    Joop S E Laven
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Center for Clinical Decision Sciences, Rotterdam, The Netherlands
    Obstet Gynecol Surv 57:755-67. 2002
    ..This review will focus on characteristics of the heterogeneous group of WHO-II patients in an attempt to identify factors involved in the etiology and possible ovulation induction outcome of PCOS...
  36. ncbi request reprint A prediction model for selecting patients undergoing in vitro fertilization for elective single embryo transfer
    Claudine C Hunault
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus University Medical Center, The, Rotterdam, Netherlands
    Fertil Steril 77:725-32. 2002
    ..Construction of a prediction model to enable the selection of patients for elective single ET...
  37. ncbi request reprint Gonadotropin therapy for the treatment of anovulation and for ovarian hyperstimulation for IVF
    Nicholas S Macklon
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus University Medical Center Rotterdam, Dr Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands
    Mol Cell Endocrinol 186:159-61. 2002
    ..Less monitoring would be required and chances for short-term complications or long term risks may be reduced...
  38. ncbi request reprint First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for in vitro fertilization
    Nicole G M Beckers
    Center for Reproductive Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
    Fertil Steril 79:621-3. 2003
    ..To report the first pregnancy and live birth after ovarian stimulation using a chimeric long-acting human recombinant FSH agonist (recFSH-CTP) for IVF...
  39. ncbi request reprint IVF outcome in anovulatory infertility (WHO group 2)--including polycystic ovary syndrome--following previous unsuccessful ovulation induction
    Annemarie G M G J Mulders
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus Medical Centre, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Reprod Biomed Online 7:50-8. 2003
    ..9). Obese women suffering from WHO 2 anovulatory infertility are at an increased risk of having their IVF cycle cancelled due to insufficient response. Once oocyte retrieval is achieved, live birth rates are comparable with controls...
  40. ncbi request reprint Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilizatio
    Nicole G M Beckers
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands
    J Clin Endocrinol Metab 88:4186-92. 2003
    ..Hence, support of corpus luteum function remains mandatory after ovarian stimulation for IVF with GnRH antagonist cotreatment...
  41. ncbi request reprint A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility
    Babak Imani
    Division of Reproductive Medicine, Rotterdam, The Netherlands
    Fertil Steril 77:91-7. 2002
    ..To establish whether initial screening characteristics of normogonadotropic anovulatory infertile women can aid in predicting live birth after induction of ovulation with clomiphene citrate (CC)...
  42. ncbi request reprint Prediction of chances for success or complications in gonadotrophin ovulation induction in normogonadotrophic anovulatory infertility
    Annemarie G M G J Mulders
    Department of Obstetrics and Gynecology, Erasmus Medical Centre, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Reprod Biomed Online 7:170-8. 2003
    ..67). The individual treatment outcome following gonadotrophin induction of ovulation may be predicted by initial screening characteristics...
  43. ncbi request reprint High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2)
    Marinus J C Eijkemans
    Center for Clinical Decision Sciences, Department of Public Health, Erasmus MC University Medical Center Rotterdam, The Netherlands
    Hum Reprod 18:2357-62. 2003
    ....
  44. ncbi request reprint Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta-analysis
    Annemarie G M G J Mulders
    Division of Reproductive Medicine, Department of Obstetrics and Gynaecology, Erasmus Medical Center, Rotterdam, The Netherlands
    Hum Reprod Update 9:429-49. 2003
    ..In conclusion, the best available evidence, though limited, suggests that the most clinically useful predictors of gonadotrophin ovulation induction outcome in normogonadotrophic women are obesity and insulin resistance...
  45. ncbi request reprint Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age
    Joop S E Laven
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus Medical Center, Rotterdam, The Netherlands
    J Clin Endocrinol Metab 89:318-23. 2004
    ..A less pronounced AMH decrease over time in these women may suggest retarded ovarian aging. The latter hypothesis, however, should be confirmed by longitudinal studies...
  46. ncbi request reprint Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency
    Babak Imani
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
    Fertil Steril 77:83-90. 2002
    ..To predict the FSH response (threshold) dose in normogonadotropic, anovulatory infertile women undergoing gonadotropin induction of ovulation...
  47. ncbi request reprint Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian aging
    Nicole G M Beckers
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus Medical Center, Rotterdam, The Netherlands
    Fertil Steril 78:291-7. 2002
    ..To investigate whether follicular phase characteristics associated with ovarian aging can be observed in women of normal reproductive age, who had previously shown a poor response to ovarian hyperstimulation for IVF...
  48. ncbi request reprint Antimüllerian hormone serum levels: a putative marker for ovarian aging
    Annemarie de Vet
    Department of Obstetrics and Gynecology, Division of Reproductive Medicine, Erasmus University Medical Center, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Fertil Steril 77:357-62. 2002
    ..To investigate whether serum concentrations of antimüllerian hormone may be used as a marker for ovarian aging...
  49. ncbi request reprint Preimplantation aneuploidy screening: a research tool for now
    Paul Devroey
    Centre of Reproductive Medicine, Brussels Free University, 1090 Brussels, Belgium
    Lancet 370:1985-6. 2007
  50. ncbi request reprint Heterozygosity for the classical galactosemia mutation does not affect ovarian reserve and menopausal age
    Erik A H Knauff
    Department of Reproduction and Gynecology, University Medical Center, Utrecht, The Netherlands
    Reprod Sci 14:780-5. 2007
    ..The authors conclude that there is no evidence that GALT mutation carriership affects ovarian reserve or menopausal age...
  51. ncbi request reprint Effect of B vitamins and genetics on success of in-vitro fertilisation
    Jolanda C Boxmeer
    Lancet 368:200. 2006
  52. ncbi request reprint Contemporary pharmacological manipulation in assisted reproduction
    Judith A F Huirne
    Division of Reproductive Medicine, Department of Obstetrics and Gynaecology, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands
    Drugs 64:297-322. 2004
    ....
  53. ncbi request reprint Reproductive biology and IVF: ovarian stimulation and luteal phase consequences
    Bart C J M Fauser
    Center for Reproductive Medicine, Erasmus Medical Center, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Trends Endocrinol Metab 14:236-42. 2003
    ..Here, we discuss recent approaches to ovarian stimulation, the induction of oocyte maturation, and effects of these altered follicular phase interventions on corpus luteum function following ovarian stimulation...
  54. ncbi request reprint Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility
    Joop S E Laven
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Erasmus Medical Center, Rotterdam, The Netherlands
    Fertil Steril 80:986-92. 2003
    ....
  55. ncbi request reprint Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients
    Erik Jansen
    Global Business Inteligence Center, NV Organon, PO Box 20, 5340 BH Oss, The Netherlands
    Mol Endocrinol 18:3050-63. 2004
    ..Presented data may contribute to a better understanding of dysregulated pathways in PCOS, which might ultimately reveal novel leads for therapeutic intervention...
  56. ncbi request reprint Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment
    Christien Weenen
    Department of Obstetrics and Gynaecology, Erasmus MC, The Netherlands
    Mol Hum Reprod 10:77-83. 2004
    ..In larger (4-8 mm) antral follicles, AMH expression gradually disappeared. In conclusion, in the human AMH expression follows a similar pattern as compared to the mouse and rat, suggesting an important role of AMH in folliculogenesis...
  57. ncbi request reprint Reproductive biology and IVF: ovarian stimulation and endometrial receptivity
    Paul Devroey
    Centre for Reproductive Medicine, University Hospital, Dutch Speaking Brussels Free University Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium
    Trends Endocrinol Metab 15:84-90. 2004
    ..The aim of this review is to analyse the effects of gonadotropin, GnRH-agonist and GnRH-antagonist administration on endometrial behaviour, to highlight the gaps in current knowledge and to propose areas in which research is needed...
  58. ncbi request reprint Predictors of recovery of ovarian function during weight gain in anorexia nervosa
    Annemarie A Van Elburg
    Rudolf Magnus Institute of Neuroscience Department of Child and Adolescent Psychiatry, University Medical Center, Utrecht, The Netherlands
    Fertil Steril 87:902-8. 2007
    ..To investigate whether serum levels of follicle-stimulating hormone (FSH), inhibin B, and anti-Müllerian hormone (AMH) can be used as predictors of recovery of ovarian function in anorexia nervosa after weight gain...